Related Experiment Video
Updated: Jun 17, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease
H Galitzer1, I Z Ben-Dov, Justin Silver
1Department of Nephrology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Abstract:
Although fibroblast growth factor 23 (FGF23) acting through its receptor Klotho-FGFR1c decreases parathyroid hormone expression, this hormone is increased in chronic kidney disease despite an elevated serum FGF23. We measured possible factors that might contribute to the resistance of parathyroid glands to FGF23 in rats with the dietary adenine-induced model of chronic kidney disease. Quantitative immunohistochemical and reverse transcription-PCR analysis using laser capture microscopy showed that both Klotho and FGFR1 protein and mRNA levels were decreased in histological sections of the parathyroid glands. Recombinant FGF23 failed to decrease serum parathyroid hormone levels or activate the mitogen-activated protein kinase signaling pathway in the glands of rats with advanced experimental chronic kidney disease. In parathyroid gland organ culture, the addition of FGF23 decreased parathyroid hormone secretion and mRNA levels in control animals or rats with early but not advanced chronic kidney disease. Our results show that because of a downregulation of the Klotho-FGFR1c receptor complex, an increase of circulating FGF23 does not decrease parathyroid hormone levels in established chronic kidney disease. This in vivo resistance is sustained in parathyroid organ culture in vitro.
Insights
In chronic kidney disease, elevated fibroblast growth factor 23 (FGF23) fails to lower parathyroid hormone due to reduced Klotho-FGFR1c receptors in parathyroid glands, causing FGF23 resistance.
Area of Science:
- Endocrinology
- Nephrology
- Molecular Biology
Background:
- Fibroblast growth factor 23 (FGF23) normally suppresses parathyroid hormone (PTH) via Klotho-FGFR1c.
- PTH levels paradoxically increase in chronic kidney disease (CKD) despite high FGF23.
- The mechanism of FGF23 resistance in CKD parathyroid glands is unclear.
Purpose of the Study:
- To investigate the factors contributing to parathyroid gland resistance to FGF23 in a rat model of CKD.
- To determine the role of Klotho-FGFR1c receptor expression in FGF23 resistance in CKD.
Main Methods:
- Dietary adenine-induced CKD model in rats.
- Quantitative immunohistochemistry and RT-PCR on laser-captured parathyroid gland sections.
- In vitro parathyroid gland organ culture with recombinant FGF23 stimulation.
Main Results:
- Klotho and FGFR1 protein and mRNA levels were significantly decreased in parathyroid glands of CKD rats.
- Recombinant FGF23 did not suppress PTH or activate MAPK signaling in advanced CKD rat parathyroid glands.
- FGF23 reduced PTH secretion and mRNA in vitro in control and early CKD, but not advanced CKD, parathyroid glands.
Conclusions:
- Downregulation of the Klotho-FGFR1c receptor complex in parathyroid glands leads to FGF23 resistance in established CKD.
- This parathyroid FGF23 resistance is evident both in vivo and in vitro.
- Therapeutic strategies targeting FGF23 signaling in CKD may need to address receptor complex restoration.
More Related Videos
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
06:39Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Introduction to Fibroblasts
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...